Marotta Asset Management
ABBV icon

Marotta Asset Management’s AbbVie ABBV Stock Holding History

Marotta Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$277K Hold
1,060
– – 0.05% 87
2026
Q2 		$266K Buy
1,060
+19
+2% +$4.09K 0.04% 90
2026
Q1 		$224K Hold
1,041
– – 0.04% 99
2025
Q4 		$238K Hold
1,041
– – 0.04% 95
2025
Q3 		$254K Buy
+1,041
New +$212K 0.05% 89
2025
Q2 		– Sell
-1,780
Closed -$352K – 106
2025
Q1 		$352K Buy
1,780
+72
+4% +$14K 0.07% 88
2024
Q4 		$306K Sell
1,708
-72
-4% -$13.2K 0.06% 96
2024
Q3 		$352K Sell
1,780
-54
-3% -$10.1K 0.07% 88
2024
Q2 		$312K Buy
1,834
+77
+4% +$12.8K 0.06% 93
2024
Q1 		$320K Hold
1,757
– – 0.07% 90
2023
Q4 		$272K Sell
1,757
-95
-5% -$13.8K 0.06% 91
2023
Q3 		$276K Buy
1,852
+250
+16% +$36.7K 0.06% 94
2023
Q2 		$216K Buy
+1,602
New +$235K 0.05% 102
2022
Q4 		$260K Sell
1,611
-93
-5% -$14.3K 0.06% 92
2022
Q3 		$229K Hold
1,704
– – 0.06% 94
2022
Q2 		$262K Buy
1,704
+93
+6% +$14.2K 0.06% 92
2022
Q1 		$261K Buy
+1,611
New +$234K 0.06% 99

Other funds holding ABBV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Marotta Asset Management's ABBV Position: Q3 2026 in Review

Marotta Asset Management held its AbbVie (ABBV) position steady in Q3 2026 at 1,060 shares worth $277K. The position accounts for 0.05% of the portfolio, ranked #87.

Marotta Asset Management first reported a position in ABBV in Q1 2022 and has held it in 17 quarters since. The position peaked at $352K in Q1 2025. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Marotta Asset Management held 1,060 shares of AbbVie worth $277K as of Q3 2026.
  • Marotta Asset Management left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.05% of Marotta Asset Management's portfolio in Q3 2026, its #87 holding.
  • Marotta Asset Management first reported a position in AbbVie in Q1 2022 and has held it in 17 quarters since.
  • Marotta Asset Management's AbbVie position peaked at $352K in Q1 2025.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Marotta Asset Management's 13F filing for Q3 2026, filed 2 Oct 2026.